Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Still Want to Be the Next Dendreon?
Motley Fool
Saturday, August 6, 2011 - 1:01pm
tags:
Dendreon, Vertex Pharmaceuticals, Incivek, hepatitis B
Doctor Who Is a Provenge Fan Says Reimbursement Is a Risk
Seeking Alpha
Saturday, August 6, 2011 - 12:59pm
tags:
Dendreon, Provenge
InterMune Loss Rise, Costs Flare Up
Yahoo/Zacks
Saturday, August 6, 2011 - 12:58pm
tags:
InterMune
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Dendreon Corporation of Class Action Lawsuit and the October 4, 2011 Lead Plaintiff Deadline
Yahoo/MarketWire
Saturday, August 6, 2011 - 12:57pm
tags:
Dendreon, lawsuits
Do Dendreon's Problems Matter to Your Biotech Portfolio?
Seeking Alpha
Saturday, August 6, 2011 - 12:56pm
tags:
Dendreon, Provenge
MannKind says it will meet with FDA about new trials of inhaled insulin Afrezza on Aug. 10
Yahoo/AP
Friday, August 5, 2011 - 1:56pm
tags:
FDA, MannKind, Afrezza, inhaled insulin, diabetes
Here's Why Dendreon Isn't Like Other Biotechs
Minyanville
Friday, August 5, 2011 - 1:55pm
tags:
Dendreon, Provenge, prostate cancer
Osiris profit edges up in 2Q
Bizjournals.com
Friday, August 5, 2011 - 1:53pm
tags:
Osiris, earnings
Is This The End Of Illumina’s Great Run?
Forbes
Friday, August 5, 2011 - 1:52pm
tags:
Illumina
Forest Labs Says Regulators Considered U.S. Business Ban on 8 Executives
Bloomberg
Friday, August 5, 2011 - 1:51pm
tags:
pharmaceutical executives, Forest Labs, Carl Icahn
Sequenom pares 2nd-quarter loss by more than half; revenue rises 17 percent
Yahoo/AP
Friday, August 5, 2011 - 1:23pm
tags:
earnings, Sequenom
Biosimilars: US payers "will want more data than FDA"
Pharma Times, UK
Friday, August 5, 2011 - 1:19pm
tags:
biosimilars, FDA
Amylin, Takeda call off obesity treatment
Bloomberg/Businessweek
Friday, August 5, 2011 - 1:17pm
tags:
Takeda, pramlintide/metreleptin, obesity, Amylin
Alere to Make 230 Million-Pound Hostile Bid for Axis-Shield
Bloomberg
Friday, August 5, 2011 - 11:48am
tags:
Alere, Axis-Shield, hostile bid, M&A, diagnostics
Novartis’s Jimenez Has Blockbuster Plans for Diovan After Patent Expires
Bloomberg
Friday, August 5, 2011 - 11:46am
tags:
Diovan, Novartis, Joe Jimenez
Here's Why Teva's Latest Report Might Worry You
Motley Fool
Friday, August 5, 2011 - 10:23am
tags:
Teva Pharmaceuticals
Momenta Pharmaceuticals - Earnings
Yahoo/InvestorsBusinessDaily
Friday, August 5, 2011 - 10:22am
tags:
Momenta, earnings
Somaxon's Bore of a Quarter
Motley Fool
Friday, August 5, 2011 - 10:13am
tags:
Somaxon, earnings
How Many Doctors Won’t Accept Samples?
Pharmalot
Friday, August 5, 2011 - 10:10am
tags:
physicians, samples
Merck cuts put pharma on top of layoffs list
Fierce Pharma
Thursday, August 4, 2011 - 4:59pm
tags:
layoffs, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.